Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells (2011)
- Authors:
- USP affiliated authors: SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP ; CARLOTTI JUNIOR, CARLOS GILBERTO - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS (TRATAMENTO); FÁRMACOS; PROTEÍNAS; APOPTOSE
- Language: Inglês
- Imprenta:
- Source:
- Título: Pediatric Blood & Cancer
- ISSN: 1545-5009
- Volume/Número/Paginação/Ano: v. 57, n. 5, p. 718, res. O044, 2011
- Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP)
-
ABNT
CASTRO-GAMERO, Angel Mauricio et al. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 28 dez. 2025. , 2011 -
APA
Castro-Gamero, A. M., Borges, K. S., Moreno, D. A., Carlotti Júnior, C. G., Scridelli, C. A., & Tone, L. G. (2011). Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Castro-Gamero AM, Borges KS, Moreno DA, Carlotti Júnior CG, Scridelli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. 2011 ; 57( 5): 718.[citado 2025 dez. 28 ] -
Vancouver
Castro-Gamero AM, Borges KS, Moreno DA, Carlotti Júnior CG, Scridelli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. 2011 ; 57( 5): 718.[citado 2025 dez. 28 ] - Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma
- Indisulam reduces viability and regulates apoptotic gene expression in pediatric high-grade glioma cells
- Tetraploidization in Wilms tumor in an infant
- Bloom's and myelodysplastic syndromes: report of a rare pediatric case with gain of an isochromosome 5p. [Carta]
- Alternative targets for medulloblastoma treatment: polo-like kinase 1
- Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines
- Inibição de exportina 7 (XPO7) sensibiliza linhagens de leucemia linfóide aguda para o tratamento com glicocorticoide
- Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells
- Avaliação da expressão dos MIR-181B-5P, MIR-100-5P e MIR-125A-5P em amostras tumorais de osteossarcoma
- TP53 P.R337H loses its function of inducing Dna damage-induced apoptosis in cell lines grown under alcaline conditions
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
